Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • PHD

  • Preventing the Next Pandemic: The Case for Investing in Circulatory Health - A Global Coalition for Circulatory Health Position Paper

    Global Heart Date published:

  • Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019

    The Lancet Date published:

  • Membranous nephropathy

    Nature Reviews Disease Primers Date published:

  • Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial

    Acta Anaesthesiologica Scandinavica Date published:

  • Serum catalytic iron and progression of chronic kidney disease: findings from the ICKD study

    Nephrology Dialysis Transplantation Date published:

  • Итоговое резюме KDIGO 2018 по гепатиту С для рекомендаций по ХБП: достижения в оценке и менеджменте

    KIDNEYS Date published:

  • Prescription Practices in Patients With Mild to Moderate CKD in India

    Kidney International Reports Date published:

  • Hydroxychloroquine Plus Standard Personal Protective Equipment Versus Standard Personal Protective Equipment Alone for the Prevention of Laboratory Confirmed Covid-19 Infections Among Healthcare Workers: A Multi-Centre Parallel Group Randomized Controlled Trial from India

    SSRN Electronic Journal Date published:

  • Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases

    The Lancet Gastroenterology & Hepatology Date published:

  • Continuous ambulatory peritoneal dialysis peritonitis guidelines - Consensus statement of peritoneal dialysis society of India - 2020

    Indian Journal of Nephrology Date published:

  • Low-value medical care in the pandemic-is this what the doctor ordered?

    The Lancet Global Health Date published:

  • Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

    Trials Date published:

  • Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region

    Nephrology Date published:

  • The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics

    Clinical Kidney Journal Date published:

  • Peritoneal dialysis: Status report in South and South East Asia

    Nephrology Date published:

  • Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial

    Contemporary Clinical Trials Date published: